Antifungal Nail Lacquer for Enhanced Transungual Delivery of Econazole Nitrate

Pharmaceutics. 2022 Oct 16;14(10):2204. doi: 10.3390/pharmaceutics14102204.

Abstract

The fungal disease of the nail, onychomycosis, which is also the most prevalent nail disturbance, demands effective topical treatment options considering the possible adverse effects of systemic antifungal therapy. The current work is focused on development of an adhesive and resistant, drug-delivering and permeation-enhancing polymeric film containing econazole nitrate (ECN) for topical antifungal treatment. The development of the lacquer formulation was guided by the Quality by Design approach to achieve the critical quality attributes needed to obtain the product of desired quality. Eudragit RSPO at 10% w/w was found to be the ideal adhesive polymer for the application and an optimal permeation-enhancing lacquer formulation was achieved by the optimization of other formulation excipients, such as plasticizer and the solvent system. Additionally, novel experimental enhancements introduced to the research included refined D50 drying time and drying rate tests for lacquer characterization as well as a multi-mechanism permeation-enhancing pre-treatment. Moreover, a practical implication was provided by a handwashing simulation designed to test the performance of the lacquer during actual use. In vitro drug release testing and ex vivo nail permeation testing demonstrated that the optimized nail lacquer performed better than control lacquer lacking the permeation enhancer by achieving a faster and sustained delivery of ECN. It can be concluded that this is a promising drug delivery system for topical antifungal treatment of onychomycotic nails, and the novel characterization techniques may be adapted for similar formulations in the future.

Keywords: drying test; econazole nitrate; handwashing simulation; lacquer characterization; nail formulation; onychomycosis; quality by design; topical antifungal treatment; ungual drug delivery.

Grants and funding

Part of the studies as well as the Graduate Assistantship for Vinam Puri were funded by the Center for Dermal Research CDR at Rutgers, The State University of New Jersey.